INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Baxter International, Inc. of Class Action Lawsuit and Upcoming Deadlines - BAX

Core Points - A class action lawsuit has been filed against Baxter International, Inc. for alleged securities fraud and unlawful business practices [2] - Baxter announced a voluntary and temporary pause in shipments and installations of its Novum LVP medical device, impacting its stock price significantly [2] Company Overview - Baxter International, Inc. is involved in the medical device sector, specifically focusing on intravenous fluid delivery systems [2] - The company has offered an alternative product, the Spectrum infusion pump, to customers affected by the pause in Novum LVP shipments [2] Financial Impact - Following the announcement of the shipment pause, Baxter's stock price dropped by $6.29 per share, representing a 22.4% decline, closing at $21.76 per share on July 31, 2025 [2]